Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
Colorcon
Express Scripts
Mallinckrodt

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer Pharma AG v. Par Pharmaceutical Inc. (D. Del. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Bayer Pharma AG v. Par Pharmaceutical Inc. (D. Del. 2013)

Docket   Start Trial Date Filed 2013-05-14
Court District Court, D. Delaware Date Terminated 2014-09-10
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties BAYER HEALTHCARE PHARMACEUTICALS INC.; BAYER INTELLECTUAL PROPERTY GMBH; BAYER PHARMA AG; PAR PHARMACEUTICAL COMPANIES INC.; PAR PHARMACEUTICAL INC.
Patents 6,362,178; 7,696,206
Attorneys David Ellis Moore; Gina R. Gencarelli; Jack B. Blumenfeld; Richard L. Horwitz; Rodger Dallery Smith , II
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Pharma AG v. Par Pharmaceutical Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Bayer Pharma AG v. Par Pharmaceutical Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-05-14 1 19. United States Patent No. 6,362,178 (herein, "the '178 patent"), entitled "…STAXYN® prior to the expiration of U.S. Patent Nos. 6,362,178 and 7,696,206. …the '178 patent or '206 patent, prior to the expiration date of the ' 178 patent or '206… 1. T his is an action for patent infringement W1der the patent laws of the United States, Title…license under the '178 patent. 22. United States Patent No. 7,696,206 (herein, " External link to document
2013-05-14 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,362,178; 7,696,206;. (mdb) … 10 September 2014 1:13-cv-00845 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Colorcon
Dow
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.